IRICoR, Centre of Excellence in Commercialization and Research, announces its membership in AUTM. Dr Nadine Beauger, Scientific Liaison Director, has attended the AUTM 2013 Annual Meeting held from February 27th to March 3rd, 2013 in San Antonio, Texas. With more than 1500 participants, the event was a huge success. IRICoR thus continues to keep abreast of best practices in Management and Commercialization of University Innovation.
To learn more about AUTM, visit their web site: http://www.autm.net/Meeting_Home2.htm
About IRICoR | Institute for Research in Immunology and Cancer – Commercialization of Research
IRICoR is a non-profit organization whose mandate is to accelerate the discovery, development and commercialization of novel drugs that originate from IRIC and Université de Montréal. IRICoR, as a Center of Excellence in Commercialization and Research, invests in highly innovative projects to rapidly transition them from academia to the market, while identifying the best development partners for these commercially-promising projects. For more information about IRICoR, please visit www.iricor.ca.
Information
Nadine Beauger Ph.D., MBA
Scientific Liaison, Director
nadine.beauger@iricor.ca
T +1 514 343.6111 ext : 0315